BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

157 related articles for article (PubMed ID: 23463520)

  • 1. Is postoperative adjuvant chemoradiotherapy necessary for high-risk oropharyngeal squamous cell carcinoma?
    Yokota T; Onitsuka T; Kusafuka K; Ogawa H; Onozawa Y; Nakagawa M; Iida Y; Kamijo T; Nishimura T; Nakajima T; Boku N; Yasui H
    Int J Clin Oncol; 2014 Feb; 19(1):38-44. PubMed ID: 23463520
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The prognostic value of extranodal extension in human papillomavirus-associated oropharyngeal squamous cell carcinoma.
    An Y; Park HS; Kelly JR; Stahl JM; Yarbrough WG; Burtness BA; Contessa JN; Decker RH; Koshy M; Husain ZA
    Cancer; 2017 Jul; 123(14):2762-2772. PubMed ID: 28323338
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The Role of Adjuvant Chemotherapy in Surgically Managed, p16-Positive Oropharyngeal Squamous Cell Carcinoma.
    Skillington SA; Kallogjeri D; Lewis JS; Piccirillo JF
    JAMA Otolaryngol Head Neck Surg; 2017 Mar; 143(3):253-259. PubMed ID: 27918781
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Patterns of Care and Comparative Effectiveness of Intensified Adjuvant Therapy for Resected Oropharyngeal Squamous Cell Carcinoma in the Human Papillomavirus Era.
    Sher DJ; Nedzi L; Khan S; Hughes R; Sumer BD; Myers LL; Truelson JM; Koshy M
    JAMA Otolaryngol Head Neck Surg; 2016 Aug; 142(8):777-88. PubMed ID: 27368076
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Primary transoral robotic surgery with concurrent neck dissection for early stage oropharyngeal squamous cell carcinoma implemented at a Danish head and neck cancer center: a phase II trial on feasibility and tumour margin status.
    Rubek N; Channir HI; Charabi BW; Lajer CB; Kiss K; Nielsen HU; Bentzen J; Friborg J; von Buchwald C
    Eur Arch Otorhinolaryngol; 2017 May; 274(5):2229-2237. PubMed ID: 28050651
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prognostic factors and survival unique to surgically treated p16+ oropharyngeal cancer.
    Haughey BH; Sinha P
    Laryngoscope; 2012 Sep; 122 Suppl 2():S13-33. PubMed ID: 22926949
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Outcomes of Patients With Single-Node Metastasis of Human Papillomavirus-Related Oropharyngeal Cancer Treated With Transoral Surgery.
    Chen SY; Sinha P; Last A; Ettyreddy A; Kallogjeri D; Pipkorn P; Rich JT; Zevallos JP; Paniello R; Puram SV; Van Abel K; Moore EJ; Oppelt P; Palka K; Adkins D; Daly M; Gay H; Thorstad WL; Jackson RS
    JAMA Otolaryngol Head Neck Surg; 2021 Jan; 147(1):16-22. PubMed ID: 33151273
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Adjuvant Chemoradiation After Surgical Resection in Elderly Patients With High-Risk Squamous Cell Carcinoma of the Head and Neck: A National Cancer Database Analysis.
    Woody NM; Ward MC; Koyfman SA; Reddy CA; Geiger J; Joshi N; Burkey B; Scharpf J; Lamarre E; Prendes B; Adelstein DJ
    Int J Radiat Oncol Biol Phys; 2017 Jul; 98(4):784-792. PubMed ID: 28602410
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Selective neck dissection and deintensified postoperative radiation and chemotherapy for oropharyngeal cancer: a subset analysis of the University of Pennsylvania transoral robotic surgery trial.
    Weinstein GS; Quon H; O'Malley BW; Kim GG; Cohen MA
    Laryngoscope; 2010 Sep; 120(9):1749-55. PubMed ID: 20717944
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clinical value of transoral robotic surgery: Nationwide results from the first 5 years of adoption.
    Li H; Torabi SJ; Park HS; Yarbrough WG; Mehra S; Choi R; Judson BL
    Laryngoscope; 2019 Aug; 129(8):1844-1855. PubMed ID: 30575965
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Postoperative concurrent chemotherapy and radiotherapy for high-risk cutaneous squamous cell carcinoma of the head and neck.
    Tanvetyanon T; Padhya T; McCaffrey J; Kish JA; Deconti RC; Trotti A; Rao NG
    Head Neck; 2015 Jun; 37(6):840-5. PubMed ID: 24623654
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Extracapsular spread and adjuvant therapy in human papillomavirus-related, p16-positive oropharyngeal carcinoma.
    Sinha P; Lewis JS; Piccirillo JF; Kallogjeri D; Haughey BH
    Cancer; 2012 Jul; 118(14):3519-30. PubMed ID: 22086669
    [TBL] [Abstract][Full Text] [Related]  

  • 13. National patterns of care and predictors of neoadjuvant and concurrent chemotherapy use with definitive radiotherapy in the treatment of patients with oropharyngeal squamous cell carcinoma.
    Sher DJ; Rusthoven CG; Khan SA; Fidler MJ; Zhu H; Koshy M
    Cancer; 2017 Jan; 123(2):273-282. PubMed ID: 27649421
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Utility of up-front transoral robotic surgery in tailoring adjuvant therapy.
    Gildener-Leapman N; Kim J; Abberbock S; Choby GW; Mandal R; Duvvuri U; Ferris RL; Kim S
    Head Neck; 2016 Aug; 38(8):1201-7. PubMed ID: 27225507
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Extracapsular extension of neck nodes and absence of human papillomavirus 16-DNA are predictors of impaired survival in p16-positive oropharyngeal squamous cell carcinoma.
    Freitag J; Wald T; Kuhnt T; Gradistanac T; Kolb M; Dietz A; Wiegand S; Wichmann G
    Cancer; 2020 Jan; 126(9):1856-1872. PubMed ID: 32032442
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Adjuvant low single dose cisplatin-based concurrent radiochemotherapy of oral cavity and oropharynx carcinoma: impact of extracapsular nodal spread on distant metastases.
    Kuhnt T; Klockenbrink U; Knipping S; Lautermann J; Kriese K; Wienke A; Hildebrandt G; Hauptmann S
    Strahlenther Onkol; 2011 May; 187(5):292-9. PubMed ID: 21533760
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Interventions for the treatment of oral cavity and oropharyngeal cancer: chemotherapy.
    Furness S; Glenny AM; Worthington HV; Pavitt S; Oliver R; Clarkson JE; Macluskey M; Chan KK; Conway DI;
    Cochrane Database Syst Rev; 2010 Sep; (9):CD006386. PubMed ID: 20824847
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Outcomes in surgically resectable oropharynx cancer treated with transoral robotic surgery versus definitive chemoradiation.
    Dhanireddy B; Burnett NP; Sanampudi S; Wooten CE; Slezak J; Shelton B; Shelton L; Shearer A; Arnold S; Kudrimoti M; Gal TJ
    Am J Otolaryngol; 2019; 40(5):673-677. PubMed ID: 31201038
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Outcomes of surgically treated human papillomavirus-related oropharyngeal squamous cell carcinoma with N3 disease.
    Zenga J; Haughey BH; Jackson RS; Adkins DR; Aranake-Chrisinger J; Bhatt N; Gay HA; Kallogjeri D; Martin EJ; Moore EJ; Paniello RC; Rich JT; Thorstad WL; Nussenbaum B
    Laryngoscope; 2017 Sep; 127(9):2033-2037. PubMed ID: 28008626
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Long term results of postoperative Intensity-Modulated Radiation Therapy (IMRT) in the treatment of Squamous Cell Carcinoma (SCC) located in the oropharynx or oral cavity.
    Hoffmann M; Saleh-Ebrahimi L; Zwicker F; Haering P; Schwahofer A; Debus J; Huber PE; Roeder F
    Radiat Oncol; 2015 Dec; 10():251. PubMed ID: 26637471
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.